The Experts below are selected from a list of 92496 Experts worldwide ranked by ideXlab platform

Bohua Chen - One of the best experts on this subject based on the ideXlab platform.

  • Novel β‐carboline‐based indole‐4,7‐quinone derivatives as NAD(P)H: Quinone‐oxidoreductase‐1 inhibitor with potent antitumor activities by inducing reactive oxygen species, apoptosis, and DNA damage
    Chemical biology & drug design, 2020
    Co-Authors: Yibing Guo, Changchun Ling, Tao Yang, Wenjie Zheng, Qingsong Guo, Bohua Chen
    Abstract:

    Eighteen new β-carboline-based indole-4,7-quinone derivatives (12a-i and 13a-i) were designed and synthesized, and their in vitro and in vivo antiproliferative activities were studied. Most of target compounds showed strong inhibition on three human tumor Cells' proliferation. In particular, the most active compound 13g not only displayed more prominent antiproliferative activities than β-lapachone, a clinical antitumor candidate, but also exerted significant NAD(P)H: quinone-oxidoreductase-1 (NQO1) inhibitory activity and NQO1-dependent cytotoxicity in HT29 Cells. Furthermore, 13g dose-dependently induced high ROS levels in HT29 Cells, and selectively inhibited cancer Cell but not non-tumor Colon Cell proliferation in vitro. Importantly, 13g promoted HT29 Cell apoptosis and DNA damage by regulating relative apoptotic proteins and H2AX expression. Finally, 13g displayed significant growth inhibition of HT29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.

  • novel β carboline based indole 4 7 quinone derivatives as nad p h quinone oxidoreductase 1 inhibitor with potent antitumor activities by inducing reactive oxygen species apoptosis and dna damage
    Chemical Biology & Drug Design, 2020
    Co-Authors: Yibing Guo, Changchun Ling, Tao Yang, Wenjie Zheng, Qingsong Guo, Bohua Chen
    Abstract:

    Eighteen new β-carboline-based indole-4,7-quinone derivatives (12a-i and 13a-i) were designed and synthesized, and their in vitro and in vivo antiproliferative activities were studied. Most of target compounds showed strong inhibition on three human tumor Cells' proliferation. In particular, the most active compound 13g not only displayed more prominent antiproliferative activities than β-lapachone, a clinical antitumor candidate, but also exerted significant NAD(P)H: quinone-oxidoreductase-1 (NQO1) inhibitory activity and NQO1-dependent cytotoxicity in HT29 Cells. Furthermore, 13g dose-dependently induced high ROS levels in HT29 Cells, and selectively inhibited cancer Cell but not non-tumor Colon Cell proliferation in vitro. Importantly, 13g promoted HT29 Cell apoptosis and DNA damage by regulating relative apoptotic proteins and H2AX expression. Finally, 13g displayed significant growth inhibition of HT29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.

Yibing Guo - One of the best experts on this subject based on the ideXlab platform.

  • Novel β‐carboline‐based indole‐4,7‐quinone derivatives as NAD(P)H: Quinone‐oxidoreductase‐1 inhibitor with potent antitumor activities by inducing reactive oxygen species, apoptosis, and DNA damage
    Chemical biology & drug design, 2020
    Co-Authors: Yibing Guo, Changchun Ling, Tao Yang, Wenjie Zheng, Qingsong Guo, Bohua Chen
    Abstract:

    Eighteen new β-carboline-based indole-4,7-quinone derivatives (12a-i and 13a-i) were designed and synthesized, and their in vitro and in vivo antiproliferative activities were studied. Most of target compounds showed strong inhibition on three human tumor Cells' proliferation. In particular, the most active compound 13g not only displayed more prominent antiproliferative activities than β-lapachone, a clinical antitumor candidate, but also exerted significant NAD(P)H: quinone-oxidoreductase-1 (NQO1) inhibitory activity and NQO1-dependent cytotoxicity in HT29 Cells. Furthermore, 13g dose-dependently induced high ROS levels in HT29 Cells, and selectively inhibited cancer Cell but not non-tumor Colon Cell proliferation in vitro. Importantly, 13g promoted HT29 Cell apoptosis and DNA damage by regulating relative apoptotic proteins and H2AX expression. Finally, 13g displayed significant growth inhibition of HT29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.

  • novel β carboline based indole 4 7 quinone derivatives as nad p h quinone oxidoreductase 1 inhibitor with potent antitumor activities by inducing reactive oxygen species apoptosis and dna damage
    Chemical Biology & Drug Design, 2020
    Co-Authors: Yibing Guo, Changchun Ling, Tao Yang, Wenjie Zheng, Qingsong Guo, Bohua Chen
    Abstract:

    Eighteen new β-carboline-based indole-4,7-quinone derivatives (12a-i and 13a-i) were designed and synthesized, and their in vitro and in vivo antiproliferative activities were studied. Most of target compounds showed strong inhibition on three human tumor Cells' proliferation. In particular, the most active compound 13g not only displayed more prominent antiproliferative activities than β-lapachone, a clinical antitumor candidate, but also exerted significant NAD(P)H: quinone-oxidoreductase-1 (NQO1) inhibitory activity and NQO1-dependent cytotoxicity in HT29 Cells. Furthermore, 13g dose-dependently induced high ROS levels in HT29 Cells, and selectively inhibited cancer Cell but not non-tumor Colon Cell proliferation in vitro. Importantly, 13g promoted HT29 Cell apoptosis and DNA damage by regulating relative apoptotic proteins and H2AX expression. Finally, 13g displayed significant growth inhibition of HT29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.

Qingsong Guo - One of the best experts on this subject based on the ideXlab platform.

  • Novel β‐carboline‐based indole‐4,7‐quinone derivatives as NAD(P)H: Quinone‐oxidoreductase‐1 inhibitor with potent antitumor activities by inducing reactive oxygen species, apoptosis, and DNA damage
    Chemical biology & drug design, 2020
    Co-Authors: Yibing Guo, Changchun Ling, Tao Yang, Wenjie Zheng, Qingsong Guo, Bohua Chen
    Abstract:

    Eighteen new β-carboline-based indole-4,7-quinone derivatives (12a-i and 13a-i) were designed and synthesized, and their in vitro and in vivo antiproliferative activities were studied. Most of target compounds showed strong inhibition on three human tumor Cells' proliferation. In particular, the most active compound 13g not only displayed more prominent antiproliferative activities than β-lapachone, a clinical antitumor candidate, but also exerted significant NAD(P)H: quinone-oxidoreductase-1 (NQO1) inhibitory activity and NQO1-dependent cytotoxicity in HT29 Cells. Furthermore, 13g dose-dependently induced high ROS levels in HT29 Cells, and selectively inhibited cancer Cell but not non-tumor Colon Cell proliferation in vitro. Importantly, 13g promoted HT29 Cell apoptosis and DNA damage by regulating relative apoptotic proteins and H2AX expression. Finally, 13g displayed significant growth inhibition of HT29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.

  • novel β carboline based indole 4 7 quinone derivatives as nad p h quinone oxidoreductase 1 inhibitor with potent antitumor activities by inducing reactive oxygen species apoptosis and dna damage
    Chemical Biology & Drug Design, 2020
    Co-Authors: Yibing Guo, Changchun Ling, Tao Yang, Wenjie Zheng, Qingsong Guo, Bohua Chen
    Abstract:

    Eighteen new β-carboline-based indole-4,7-quinone derivatives (12a-i and 13a-i) were designed and synthesized, and their in vitro and in vivo antiproliferative activities were studied. Most of target compounds showed strong inhibition on three human tumor Cells' proliferation. In particular, the most active compound 13g not only displayed more prominent antiproliferative activities than β-lapachone, a clinical antitumor candidate, but also exerted significant NAD(P)H: quinone-oxidoreductase-1 (NQO1) inhibitory activity and NQO1-dependent cytotoxicity in HT29 Cells. Furthermore, 13g dose-dependently induced high ROS levels in HT29 Cells, and selectively inhibited cancer Cell but not non-tumor Colon Cell proliferation in vitro. Importantly, 13g promoted HT29 Cell apoptosis and DNA damage by regulating relative apoptotic proteins and H2AX expression. Finally, 13g displayed significant growth inhibition of HT29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.

Changchun Ling - One of the best experts on this subject based on the ideXlab platform.

  • Novel β‐carboline‐based indole‐4,7‐quinone derivatives as NAD(P)H: Quinone‐oxidoreductase‐1 inhibitor with potent antitumor activities by inducing reactive oxygen species, apoptosis, and DNA damage
    Chemical biology & drug design, 2020
    Co-Authors: Yibing Guo, Changchun Ling, Tao Yang, Wenjie Zheng, Qingsong Guo, Bohua Chen
    Abstract:

    Eighteen new β-carboline-based indole-4,7-quinone derivatives (12a-i and 13a-i) were designed and synthesized, and their in vitro and in vivo antiproliferative activities were studied. Most of target compounds showed strong inhibition on three human tumor Cells' proliferation. In particular, the most active compound 13g not only displayed more prominent antiproliferative activities than β-lapachone, a clinical antitumor candidate, but also exerted significant NAD(P)H: quinone-oxidoreductase-1 (NQO1) inhibitory activity and NQO1-dependent cytotoxicity in HT29 Cells. Furthermore, 13g dose-dependently induced high ROS levels in HT29 Cells, and selectively inhibited cancer Cell but not non-tumor Colon Cell proliferation in vitro. Importantly, 13g promoted HT29 Cell apoptosis and DNA damage by regulating relative apoptotic proteins and H2AX expression. Finally, 13g displayed significant growth inhibition of HT29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.

  • novel β carboline based indole 4 7 quinone derivatives as nad p h quinone oxidoreductase 1 inhibitor with potent antitumor activities by inducing reactive oxygen species apoptosis and dna damage
    Chemical Biology & Drug Design, 2020
    Co-Authors: Yibing Guo, Changchun Ling, Tao Yang, Wenjie Zheng, Qingsong Guo, Bohua Chen
    Abstract:

    Eighteen new β-carboline-based indole-4,7-quinone derivatives (12a-i and 13a-i) were designed and synthesized, and their in vitro and in vivo antiproliferative activities were studied. Most of target compounds showed strong inhibition on three human tumor Cells' proliferation. In particular, the most active compound 13g not only displayed more prominent antiproliferative activities than β-lapachone, a clinical antitumor candidate, but also exerted significant NAD(P)H: quinone-oxidoreductase-1 (NQO1) inhibitory activity and NQO1-dependent cytotoxicity in HT29 Cells. Furthermore, 13g dose-dependently induced high ROS levels in HT29 Cells, and selectively inhibited cancer Cell but not non-tumor Colon Cell proliferation in vitro. Importantly, 13g promoted HT29 Cell apoptosis and DNA damage by regulating relative apoptotic proteins and H2AX expression. Finally, 13g displayed significant growth inhibition of HT29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.

Tao Yang - One of the best experts on this subject based on the ideXlab platform.

  • Novel β‐carboline‐based indole‐4,7‐quinone derivatives as NAD(P)H: Quinone‐oxidoreductase‐1 inhibitor with potent antitumor activities by inducing reactive oxygen species, apoptosis, and DNA damage
    Chemical biology & drug design, 2020
    Co-Authors: Yibing Guo, Changchun Ling, Tao Yang, Wenjie Zheng, Qingsong Guo, Bohua Chen
    Abstract:

    Eighteen new β-carboline-based indole-4,7-quinone derivatives (12a-i and 13a-i) were designed and synthesized, and their in vitro and in vivo antiproliferative activities were studied. Most of target compounds showed strong inhibition on three human tumor Cells' proliferation. In particular, the most active compound 13g not only displayed more prominent antiproliferative activities than β-lapachone, a clinical antitumor candidate, but also exerted significant NAD(P)H: quinone-oxidoreductase-1 (NQO1) inhibitory activity and NQO1-dependent cytotoxicity in HT29 Cells. Furthermore, 13g dose-dependently induced high ROS levels in HT29 Cells, and selectively inhibited cancer Cell but not non-tumor Colon Cell proliferation in vitro. Importantly, 13g promoted HT29 Cell apoptosis and DNA damage by regulating relative apoptotic proteins and H2AX expression. Finally, 13g displayed significant growth inhibition of HT29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.

  • novel β carboline based indole 4 7 quinone derivatives as nad p h quinone oxidoreductase 1 inhibitor with potent antitumor activities by inducing reactive oxygen species apoptosis and dna damage
    Chemical Biology & Drug Design, 2020
    Co-Authors: Yibing Guo, Changchun Ling, Tao Yang, Wenjie Zheng, Qingsong Guo, Bohua Chen
    Abstract:

    Eighteen new β-carboline-based indole-4,7-quinone derivatives (12a-i and 13a-i) were designed and synthesized, and their in vitro and in vivo antiproliferative activities were studied. Most of target compounds showed strong inhibition on three human tumor Cells' proliferation. In particular, the most active compound 13g not only displayed more prominent antiproliferative activities than β-lapachone, a clinical antitumor candidate, but also exerted significant NAD(P)H: quinone-oxidoreductase-1 (NQO1) inhibitory activity and NQO1-dependent cytotoxicity in HT29 Cells. Furthermore, 13g dose-dependently induced high ROS levels in HT29 Cells, and selectively inhibited cancer Cell but not non-tumor Colon Cell proliferation in vitro. Importantly, 13g promoted HT29 Cell apoptosis and DNA damage by regulating relative apoptotic proteins and H2AX expression. Finally, 13g displayed significant growth inhibition of HT29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.